Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indinavir and Efavirenz Dosing Study in HIV
NCT00002387Phase 2Completed
- Sponsor
- Merck & Co.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indinavir in human immunodeficiency virus infection (HIV), sponsored by Merck & Co.. Status: completed.
02
Drugs
indinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002387.